Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)

OBJECTIVE: The MITIGATE study aims to evaluate the real-world clinical effectiveness of pre-treatment with icosapent ethyl (IPE), compared with usual care, on laboratory-confirmed viral upper respiratory infection (URI)-related morbidity and mortality in adults with established atherosclerotic cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrosy, Andrew P., Malik, Umar I., Thomas, Rachel C., Parikh, Rishi V., Tan, Thida C., Goh, Choon H., Selby, Van N., Solomon, Matthew D., Avula, Harshith R., Fitzpatrick, Jesse K., Skarbinski, Jacek, Philip, Sephy, Granowitz, Craig, Bhatt, Deepak L., Go, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843090/
https://www.ncbi.nlm.nih.gov/pubmed/33516752
http://dx.doi.org/10.1016/j.ahj.2021.01.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843090/
https://www.ncbi.nlm.nih.gov/pubmed/33516752
http://dx.doi.org/10.1016/j.ahj.2021.01.018

Ejemplares similares